Glaukos (GKOS) Net Cash Flow Growth (3y) (2017 - 2026)
Glaukos (GKOS) Net Cash Flow Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | -48.90% |
| 10 | Glaukos | 8.67 Bn | 8.56 Bn | 117.23 Mn | 32.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.31% |
| Dec 31, 2025 | -35.87% |
| Sep 30, 2025 | -84.06% |
| Jun 30, 2025 | -67.26% |
| Mar 31, 2025 | -129.72% |
| Dec 31, 2024 | 100.68% |
| Sep 30, 2024 | 107.66% |
| Jun 30, 2024 | 4.92% |
| Mar 31, 2024 | -436.29% |
| Dec 31, 2023 | -44.71% |
| Sep 30, 2023 | 27.58% |
| Jun 30, 2023 | -56.97% |
| Mar 31, 2023 | -73.97% |
| Dec 31, 2022 | -17.91% |
| Sep 30, 2022 | 93.61% |
| Jun 30, 2022 | -33.71% |
| Mar 31, 2022 | 10.66% |
| Dec 31, 2021 | -121.17% |
| Sep 30, 2021 | -33.07% |
| Jun 30, 2021 | 33.15% |